Clinical Manifestations Associated with Overweight/Obesity in Puerto Ricans with Fibromyalgia Syndrome

• Published in: Journal of Obesity 2016-01, Vol.2016 (2016), p.6-12
• Main Authors: Fred-Jimenez, Ruth M, Arroyo-Avila, Mariangeli, Mayor, Angel M, Rios, Grissel, Vila, Luis M
• Format: Article
• Language: English
• Subjects: Adult; Anxiety; Arthritis; Asthma; Body mass index; Cardiovascular disease; Care and treatment; Comorbidity; Complications and side effects; Coronary vessels; Cross-Sectional Studies; Cytokines; Exercise; Female; Fibromyalgia; Fibromyalgia - complications; Fibromyalgia - epidemiology; Fibromyalgia - physiopathology; Health aspects; Health Behavior; Hispanic Americans - statistics & numerical data; Humans; Hypertension; Internal medicine; Male; Medicine; Memory Disorders - epidemiology; Memory Disorders - etiology; Memory Disorders - physiopathology; Middle Aged; Nonsteroidal anti-inflammatory drugs; Obesity; Obesity - complications; Obesity - epidemiology; Obesity - physiopathology; Pain; Physical fitness; Puerto Ricans; Puerto Rico - ethnology; Quality of life; Rheumatology; Sleep; Studies; United States - epidemiology; Urinary Bladder, Overactive - epidemiology; Urinary Bladder, Overactive - etiology; Urinary Bladder, Overactive - physiopathology; Weight control
• ISSN: 2090-0708; 2090-0716
• DOI: 10.1155/2016/1379289

Objective. To determine the clinical manifestations associated with overweight/obesity in Hispanics from Puerto Rico with fibromyalgia syndrome (FMS). Methods. A cross-sectional study was performed in 144 patients with FMS (per American College of Rheumatology (ACR) classification criteria). Sociodemographic features, FMS-related symptoms, tender points (per ACR criteria), comorbidities, and FMS treatment were examined. BMI was calculated and patients were grouped into two categories: BMI ≤ 24.9 kg/m2 (nonoverweight/obese) and BMI ≥ 25 kg/m2 (overweight/obese). Bivariate and multivariate analyses were used to evaluate differences between the study groups. Results. The mean (standard deviation (SD)) age of patients was 50.2 (9.9) years; 95.1% were females and 75.7% were overweight/obese. In the bivariate analysis, overweight/obese patients were more likely to have self-reported memory impairment, anxiety, shortness of breath, and urinary frequency than nonoverweight/obese patients. In addition, the tender point count was higher in the overweight/obese group. In the logistic regression analyses, self-reported memory impairment and urinary frequency differences remained significant after adjusting for confounding variables. Conclusion. In this population of Puerto Ricans with FMS, overweight/obese patients experienced more FMS-related manifestations than nonoverweight/obese individuals. However, prospective studies are needed to confirm these associations and to elucidate if weight reduction interventions could favorably impact the severity of FMS.